Olema Pharmaceuticals, Inc. OLMA
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-11-19
Olema Pharmaceuticals, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 3,999,518 | $43.3M | 4.6% |
| TWO SIGMA INVESTMENTS, LP | 1,131,434 | $14.2M | 1.3% |
| Point72 Asset Management, L.P. | 1,093,349 | $13.7M | 1.26% |
| CITADEL ADVISORS LLC | 725,628 | $9.1M | 0.83% |
| AQR CAPITAL MANAGEMENT LLC | 78,161 | $977,794 | 0.09% |
| D. E. Shaw & Co., Inc. | 55,519 | $694,543 | 0.06% |
| Duquesne Family Office LLC | 986,827 | $12,345 | 1.13% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.